Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access March 20, 2014

Head and Neck Squamous Cell Carcinoma: Prognosis using molecular approach

  • Tarikul Mazumder EMAIL logo , Sayantan Nath , Nibendu Nath and Munish Kumar
From the journal Open Life Sciences

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the fifth most prevalent cancer worldwide. Apart from various known clinicopathogical factors, it is still a major concern as many genetic and epigenetic alterations bring about the possibility of this deadly disease. The aim of this review is to explore the possible role of DNA repair pathways and the polymorphic status of DNA repair genes (XPA, XPC, XPD, XRCC1 and XRCC3) in the onset of HNSCC, along with sequence variations in genes such as Glutathione S-transferases (GSTT1, M1 and P1) that are significantly associated with HNSCC risk. We also focus on the p53 gene mutation induced by various etiological agents and threat factors with its implications towards HNSCC, and emphasise the current therapeutic interventions in treating HNSCC.

[1] Hiyama T., Yoshihara M., Tanaka S., Chayama K., Genetic polymorphisms and head and neck cancer risk (Review), Int. J. Oncol., 2008, 32, 945–973 10.3892/ijo.32.5.945Search in Google Scholar

[2] Masood N., Yasmin A., and Kayani M.A., Genetic deletions of GSTM1 and GSTT1 in head and neck cancer: review of the literature from 2000 to 2012, Asian Pac. J. Cancer Prev., 2013, 14, 3535–3539 10.7314/APJCP.2013.14.6.3535Search in Google Scholar

[3] Stadler M.E., Patel M.R., Couch M.E., Hayes D.N., Molecular biology of head and neck cancer: risks and pathways, Hematol. Oncol. Clin. North Am., 2008, 22, 1099–1124 10.1016/j.hoc.2008.08.007Search in Google Scholar PubMed PubMed Central

[4] Flores-Obando R.E., Gollin S.M., Ragin C.C., Polymorphisms in DNA damage response genes and head and neck cancer risk, Biomarkers, 2010, 15, 379–399 10.3109/13547501003797664Search in Google Scholar PubMed PubMed Central

[5] Ramachandran S., Ramadas K., Hariharan R., Rejnish Kumar R., Radhakrishna Pillai M., Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer, Oral Oncol., 2006, 42, 350–362 10.1016/j.oraloncology.2005.08.010Search in Google Scholar PubMed

[6] Ho T., Wei Q., Sturgis E.M., Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck, Head Neck, 2007, 29, 682–699 10.1002/hed.20570Search in Google Scholar PubMed

[7] Hall J., Hashibe M., Boffetta P., Gaborieau V., Moullan N., Chabrier A., et al., The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract, Carcinogenesis, 2007, 28, 665–671 10.1093/carcin/bgl160Search in Google Scholar PubMed

[8] Abbasi R., Ramroth H., Becher H., Dietz A., Schmezer P., Popanda O., Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes, Int. J. Cancer, 2009, 125, 1431–1439 10.1002/ijc.24442Search in Google Scholar PubMed

[9] Shen H., Sturgis E.M., Khan S.G., Qiao Y., Shahlavi T., Eicher S.A., et al., An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study, Cancer Res., 2001, 61, 3321–3325 Search in Google Scholar

[10] Yang M., Kang M.J., Choi Y., Kim C.S., Lee S.M., Park C.W., et al., Associations between XPC expression, genotype, and the risk of head and neck cancer, Environ. Mol. Mutagen 2005, 45, 374–379 10.1002/em.20097Search in Google Scholar PubMed

[11] Sturgis E.M., Zheng R., Li L., Castillo E.J., Eicher S.A., Chen M, et al., XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis, Carcinogenesis, 2000, 21, 2219–2223 10.1093/carcin/21.12.2219Search in Google Scholar PubMed

[12] Majumder M., Sikdar N., Ghosh S., Roy B., Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators, Int. J. Cancer, 2007, 120,2148–2156 10.1002/ijc.22547Search in Google Scholar PubMed

[13] Harth V., Schafer M., Abel J., Maintz L., Neuhaus T., Besuden M., et al., Head and neck squamouscell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair, J. Toxicol. Environ. Health A., 2008, 71, 887–897 10.1080/15287390801988160Search in Google Scholar PubMed

[14] Kowalski M., Przybylowska K., Rusin P., Olszewski J., Morawiec-Sztandera A., Bielecka-Kowalska A., et al., Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck, J. Exp. Clin. Cancer Res., 2009, 28, 37 10.1186/1756-9966-28-37Search in Google Scholar PubMed PubMed Central

[15] Huang W.Y., Olshan A.F., Schwartz S.M., Berndt S.I., Chen C., Llaca V., et al., Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis, Cancer Epidemiol Biomarkers Prev., 2005, 14, 1747–1753 10.1158/1055-9965.EPI-05-0162Search in Google Scholar PubMed

[16] Werbrouck J., De Ruyck K., Duprez F., Van Eijkeren M., Rietzschel E., Bekaert S., et al., Single-nucleotide polymorphisms in DNA doublestrand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption, Mutat. Res., 2008, 656, 74–81 10.1016/j.mrgentox.2008.07.013Search in Google Scholar PubMed

[17] Ye Z., Song H., Guo Y., Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis, J. Med. Genet., 2004, 41, 360–365 10.1136/jmg.2003.016246Search in Google Scholar PubMed PubMed Central

[18] Johnson N., Tobacco use and oral cancer: a global perspective, J. Dent. Educ., 2001, 65, 328–339 10.1002/j.0022-0337.2001.65.4.tb03403.xSearch in Google Scholar

[19] Fortini P., Pascucci B., Parlanti E., D’Errico M., Simonelli V., Dogliotti E., The base excision repair: mechanisms and its relevance for cancer susceptibility, Biochimie., 2003, 85, 1053–1071 10.1016/j.biochi.2003.11.003Search in Google Scholar PubMed

[20] Fleck O., Nielsen O., DNA repair, J. Cell Sci., 2004, 117, 515–517 10.1242/jcs.00952Search in Google Scholar PubMed

[21] Hoeijmakers J.H., Genome maintenance mechanisms for preventing cancer, Nature, 2001, 411, 366–374 10.1038/35077232Search in Google Scholar PubMed

[22] Hakem R., DNA-damage repair; the good, the bad, and the ugly, EMBO J., 2008, 27, 589–605 10.1038/emboj.2008.15Search in Google Scholar PubMed PubMed Central

[23] Shen M.R., Jones I.M., Mohrenweiser H., Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans, Cancer Res., 1998, 58, 604–608 Search in Google Scholar

[24] Lou Y., Peng W.J., Cao D.S., Xie. J., Li H.H., Jiang Z.X., DNA Repair Gene XRCC1 Polymorphisms and Head and Neck Cancer Risk: An Updated Meta-Analysis Including 16344 Subjects, PLoS One, 2013, 8, DOI: 10.1371 10.1371/journal.pone.0074059Search in Google Scholar PubMed PubMed Central

[25] Yuan H., Li H., Ma H., Niu Y., Wu Y., Zhang S., et al., Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population, Exp. Ther. Med., 2012, 3, 719–724 10.3892/etm.2012.476Search in Google Scholar PubMed PubMed Central

[26] Li C., Hu Z., Lu J., Liu Z., Wang LE., El-Naggar A.K., et al., Genetic polymorphisms in DNA baseexcision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck, Cancer, 2007, 110, 867–875 10.1002/cncr.22861Search in Google Scholar PubMed

[27] Csejtei A., Tibold A., Koltai K., Varga Z., Szanyi I., Gobel G., et al., Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population, Anticancer Res., 2009, 29, 4169–4173 Search in Google Scholar

[28] Jelonek K., Gdowicz-Klosok A., Pietrowska M., Borkowska M., Korfanty J., Rzeszowska-Wolny J, et al., Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population, J. Appl. Genet., 2010, 51, 343–352 10.1007/BF03208865Search in Google Scholar PubMed

[29] Gugatschka M., Dehchamani D., Wascher T.C., Friedrich G., Renner W., DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck, Exp. Mol. Pathol., 2011, 91, 331–334 10.1016/j.yexmp.2011.03.004Search in Google Scholar PubMed

[30] Demokan S., Demir D., Suoglu Y., Kiyak E., Akar U., Dalay N., Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer, Pathol. Oncol. Res., 2005, 11, 22–25 10.1007/BF03032401Search in Google Scholar PubMed

[31] Kietthubthew S., Sriplung H., Au W.W., Ishida T., Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand, Int. J. Hyg. Environ. Health, 2006, 209, 21–29 10.1016/j.ijheh.2005.06.002Search in Google Scholar PubMed

[32] Mahjabeen I., Baig R.M., Masood N., Sabir M., Inayat U., Malik F.A., et al., Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients, Pathol. Oncol. Res., 2013, 19, 183–188 10.1007/s12253-012-9567-zSearch in Google Scholar PubMed

[33] Kumar A., Pant M.C., Singh H.S., Khandelwal S., Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population, Mutat.Res., 2012, 729, 24–34 10.1016/j.mrfmmm.2011.09.001Search in Google Scholar PubMed

[34] Khlifi R., Kallel I., Hammami B., Hamza-Chaffai A., Rebai A., DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population, J. Oral Pathol. Med., 2013, DOI:10.1111 10.1111/jop.12114Search in Google Scholar

[35] Majumder M., Sikdar N., Paul R.R., Roy B., Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280), Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2106–2112 10.1158/1055-9965.EPI-05-0108Search in Google Scholar

[36] Christmann M., Tomicic M.T., Roos W.P., Kaina B., Mechanisms of human DNA repair: an update, Toxicology, 2003,193,3–34 10.1016/S0300-483X(03)00287-7Search in Google Scholar

[37] An J., Liu Z., Hu Z., Li G., Wang L.E., Sturgis E.M., et al., Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck, Cancer Epidemiol. Biomarkers Prev., 2007,16,1633–1638 10.1158/1055-9965.EPI-07-0252Search in Google Scholar PubMed

[38] Ding D., Zhang Y., Yu H., Guo Y., Jiang L., He X., et al., Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis, Int. J. Cancer, 2012,131,488–496 10.1002/ijc.26391Search in Google Scholar PubMed

[39] Liu J., Zhang Z., Cao X.L., Lei D.P., Wang Z.Q., Jin T., et al., XPA A23G polymorphism and susceptibility to cancer: a meta-analysis, Mol. Biol. Rep., 2012,39,6791–6799 10.1007/s11033-012-1504-4Search in Google Scholar PubMed

[40] Bau D.T., Tsai M.H., Huang C.Y., Lee C.C., Tseng H.C., Lo Y.L., et al., Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit, Chin. J. Physiol., 2007,50,294–300 Search in Google Scholar

[41] Sugimura T., Kumimoto H., Tohnai I., Fukui T., Matsuo K., Tsurusako S., et al., Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms, J. Oral Pathol. Med., 2006,35,11–18 10.1111/j.1600-0714.2005.00364.xSearch in Google Scholar PubMed

[42] Khlifi R., Rebai A., Hamza-Chaffai A., Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma, J. Genet., 2012,91,375–384 10.1007/s12041-012-0193-zSearch in Google Scholar PubMed

[43] Wang F., Chang D., Hu F.L., Sui H., Han B., Li D.D., et al., DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 casecontrol studies, Cancer Epidemiol. Biomarkers Prev., 2008,17,507–517 10.1158/1055-9965.EPI-07-2507Search in Google Scholar PubMed

[44] Sliwinski T., Przybylowska K., Markiewicz L., Rusin P., Pietruszewska W., Zelinska-Blizniewska H., et al., MUTYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case control study, Mol. Biol. Rep., 2011,38,1251–1261 10.1007/s11033-010-0224-xSearch in Google Scholar PubMed

[45] Francisco G., Menezes P.R., Eluf-Neto J., Chammas R., XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis, Eur. J. Hum. Genet., 2008,16,724–734 10.1038/ejhg.2008.6Search in Google Scholar PubMed

[46] Wang Y, Spitz M.R., Lee J.J., Huang M, Lippman S.M., Wu X., Nucleotide excision repair pathway genes and oral premalignant lesions, Clin. Cancer Res., 2007,13,3753–3758 10.1158/1078-0432.CCR-06-1911Search in Google Scholar PubMed

[47] Khanna K.K., Jackson S.P., DNA double-strand breaks: signaling, repair and the cancer connection, Nat. Genet., 2001,27,247–254 10.1038/85798Search in Google Scholar PubMed

[48] Rothkamm K., Kruger I., Thompson L.H., Lobrich M., Pathways of DNA double-strand break repair during the mammalian cell cycle, Mol. Cell Biol., 2003,23,5706–5715 10.1128/MCB.23.16.5706-5715.2003Search in Google Scholar PubMed PubMed Central

[49] Helleday T., Lo J., van Gent D.C., Engelward B.P., DNA double-strand break repair: from mechanistic understanding to cancer treatment, DNA Repair (Amst), 2007,6,923–935 10.1016/j.dnarep.2007.02.006Search in Google Scholar PubMed

[50] Mahaney B.L., Meek K., Lees-Miller S.P., Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining, Biochem. J., 2009,417,639–650 10.1042/BJ20080413Search in Google Scholar PubMed PubMed Central

[51] Riballo E., Woodbine L., Stiff T., Walker S.A., Goodarzi A.A., Jeggo P.A., XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation, Nucleic Acids Res., 2009,37, 482–492 10.1093/nar/gkn957Search in Google Scholar PubMed PubMed Central

[52] Yin Q.H., Liu C., Li L., Zu X.Y., Wang Y.J., Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a metaanalysis of case-control studies, Asian Pac. J. Cancer Prev., 2012,13,5201–5205 10.7314/APJCP.2012.13.10.5201Search in Google Scholar

[53] Kurumizaka H., Ikawa S., Nakada M., Eda K., Kagawa W., Takata M., et al., Homologouspairing activity of the human DNA-repair proteins Xrcc3.Rad51C, Proc. Natl. Acad. Sci. U S A., 2001,98,5538–5543 10.1073/pnas.091603098Search in Google Scholar PubMed PubMed Central

[54] Shen H., Sturgis E.M., Dahlstrom K.R., Zheng Y., Spitz M.R., Wei Q., A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis, Int. J. Cancer, 2002,99,869–872 10.1002/ijc.10413Search in Google Scholar PubMed

[55] Wen S.X., Zhang X.M., Tang P.Z., Zhao D., Guo Y.L., Tan W., et al., Association between genetic polymorphism in DNA repair genes XRCC3 and risks of laryngeal and hypopharyngeal carcinomas, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2007,42,856–859 Search in Google Scholar

[56] Sliwinski T., Walczak A., Przybylowska K., Rusin P., Pietruszewska W., Zielinska-Blizniewska H., et al., Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population, Exp. Mol. Pathol., 2010,89,358–366 10.1016/j.yexmp.2010.08.005Search in Google Scholar

[57] Yang H., Lippman S.M., Huang M., Jack Lee J., Wang W., Spitz M.R., et al., Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions, Eur. J. Cancer, 2008,44,1603–1611 10.1016/j.ejca.2008.05.006Search in Google Scholar

[58] Jacob S., Praz F., DNA mismatch repair defects: role in colorectal carcinogenesis, Biochimie., 2002, 84, 27–47 10.1016/S0300-9084(01)01362-1Search in Google Scholar

[59] Wang M., Chu H., Zhang Z., Wei Q., Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer, J. Biomed. Res., 2013, 27, 179–192 Search in Google Scholar

[60] Jha R., Gaur P., Sharma S.C., Das S.N., Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians, Gene, 2013, 526, 223–227 10.1016/j.gene.2013.05.014Search in Google Scholar

[61] Kumar M., Agarwal S.K., Goel S.K., Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking, Mol. Cell Biochem., 2009,322,73–79 10.1007/s11010-008-9941-zSearch in Google Scholar

[62] McIlwain C.C., Townsend D.M., Tew K.D., Glutathione S-transferase polymorphisms: cancer incidence and therapy, Oncogene, 2006,25,1639–1648 10.1038/sj.onc.1209373Search in Google Scholar

[63] Johns L.E., Houlston R.S., Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis, Mutagenesis, 2000,15,399–404 10.1093/mutage/15.5.399Search in Google Scholar

[64] Ford J.G., Li Y., O’Sullivan M.M., Demopoulos R., Garte S., Taioli E., et al., Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans, Carcinogenesis, 2000,21,1971–1975 10.1093/carcin/21.11.1971Search in Google Scholar

[65] Wei B., Xu Z., Zhou Y., Ruan J., Cheng H., Xi B., et al., Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies, PLoS One, 2012,7,e46982 10.1371/journal.pone.0046982Search in Google Scholar

[66] McWilliams J.E., Evans A.J., Beer T.M., Andersen P.E., Cohen J.I., Everts E.C., et al., Genetic polymorphisms in head and neck cancer risk, Head Neck, 2000,22,609–617 10.1002/1097-0347(200009)22:6<609::AID-HED10>3.0.CO;2-LSearch in Google Scholar

[67] Ko Y., Abel J., Harth V., Brode P., Antony C., Donat S., et al., Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of TP53 in tumor tissue, Cancer Res., 2001,61,4398–4404 Search in Google Scholar

[68] Capoluongo E., Almadori G., Concolino P., Bussu F., Santonocito C., Vendittelli F., et al., GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio Region, Clin. Chim. Acta., 2007,376,174–178 10.1016/j.cca.2006.08.017Search in Google Scholar

[69] Sato M., Sato T., Izumo T., Amagasa T., Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes, Oral Oncol., 2000,36,267–271 10.1016/S1368-8375(99)00090-1Search in Google Scholar

[70] Leme C.V., Raposo L.S., Ruiz M.T., Biselli J.M., Galbiatti A.L., Maniglia J.V., et al., GSTM1 and GSTT1 genes analysis in head and neck cancer patients, Rev. Assoc. Med. Bras., 2010,56,299–303 10.1590/S0104-42302010000300013Search in Google Scholar

[71] Singh M., Shah P.P., Singh A.P., Ruwali M., Mathur N., Pant M.C., et al., Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer, Mutat. Res., 2008,638,184–194 10.1016/j.mrfmmm.2007.10.003Search in Google Scholar

[72] Nosheen M., Ishrat M., Malik F.A., Baig R.M., Kayani M.A., Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study, Asian Pac. J. Cancer Prev., 2010,11,881–885 Search in Google Scholar

[73] Cadoni G., Boccia S., Petrelli L., Di Giannantonio P., Arzani D, Giorgio A., et al., A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism, Acta. Otorhinolaryngol. Ital., 2012,32,1–11 Search in Google Scholar

[74] Hashibe M., Brennan P., Strange R.C., Bhisey R., Cascorbi I., Lazarus P., et al., Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer, Cancer Epidemiol Biomarkers Prev., 2003,12,1509–1517 Search in Google Scholar

[75] Evans A.J., Henner W.D., Eilers K.M., Montalto M.A., Wersinger E.M., Andersen P.E., et al., Polymorphisms of GSTT1 and related genes in head and neck cancer risk, Head Neck, 2004,26, 63–70 10.1002/hed.10342Search in Google Scholar

[76] Gronau S., Koenig-Greger D., Jerg M., Riechelmann H., Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?, Otolaryngol Head Neck Surg., 2003,128,674–680 10.1016/S0194-5998(03)00176-1Search in Google Scholar

[77] Oude Ophuis M.B., Roelofs H.M., van den Brandt P.A., Peters W.H., Manni J.J., Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility, Head Neck, 2003,25,37–43 10.1002/hed.10182Search in Google Scholar PubMed

[78] Reszka E., Czekaj P., Adamska J., Wasowicz W., Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers, Clin. Chem. Lab. Med., 2008,46,1090–1096 10.1515/CCLM.2008.227Search in Google Scholar PubMed

[79] Wong R.S., Apoptosis in cancer: from pathogenesis to treatment, J. Exp. Clin. Cancer Res., 2011,30,87 10.1186/1756-9966-30-87Search in Google Scholar PubMed PubMed Central

[80] Benard J., Douc-Rasy S., Ahomadegbe J.C., TTP53 family members and human cancers, Hum. Mutat., 2003,21,182–191 10.1002/humu.10172Search in Google Scholar PubMed

[81] Belyi V.A., Ak P., Markert E., Wang H., Hu W., Puzio-Kuter A., et al., The origins and evolution of the TP53 family of genes, Cold Spring Harb Perspect Biol., 2010,2,a001198 10.1101/cshperspect.a001198Search in Google Scholar

[82] Nagai M.A., Miracca E.C., Yamamoto L., Moura R.P., Simpson A.J., Kowalski L.P., et al., TTP53 genetic alterations in head-and-neck carcinomas from Brazil, Int. J. Cancer, 1998,76,13–18 10.1002/(SICI)1097-0215(19980330)76:1<13::AID-IJC3>3.0.CO;2-0Search in Google Scholar

[83] Peltonen J.K., Helppi H.M., Paakko P., Turpeenniemi-Hujanen T., Vahakangas K.H., TP53 in head and neck cancer: functional consequences and environmental implications of TTP53 mutations, Head Neck Oncol, 2010,2,36 10.1186/1758-3284-2-36Search in Google Scholar

[84] Poeta M.L., Manola J., Goldwasser M.A., Forastiere A., Benoit N., Califano J.A., et al., TTP53 mutations and survival in squamous-cell carcinoma of the head and neck, N. Engl. J. Med., 2007,357, 2552–2561 10.1056/NEJMoa073770Search in Google Scholar

[85] Mitra S., Banerjee S., Misra C., Singh R.K., Roy A., Sengupta A., et al., Interplay between human papilloma virus infection and TP53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population, J. Clin. Pathol., 2007,60,1040–1047 10.1136/jcp.2005.034835Search in Google Scholar

[86] Barakat K., Issack B.B., Stepanova M., Tuszynski J., Effects of temperature on the TP53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant, PLoS One, 2011,6,e27651 10.1371/journal.pone.0027651Search in Google Scholar

[87] Galli P., Cadoni G., Volante M., De Feo E., Amore R., Giorgio A., et al., A case-control study on the combined effects of TP53 and p73 polymorphisms on head and neck cancer risk in an Italian population, BMC Cancer, 2009,9,137 10.1186/1471-2407-9-137Search in Google Scholar

[88] Hsieh L.L., Wang P.F., Chen I.H., Liao C.T., Wang H.M., Chen M.C., et al., Characteristics of mutations in the TP53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese, Carcinogenesis, 2001,22,1497–1503 10.1093/carcin/22.9.1497Search in Google Scholar

[89] Jamaly S., Khanehkenari M.R., Rao R., Patil G., Thakur S., Ramaswamy P., et al., Relationship between TP53 overexpression, human papillomavirus infection, and lifestyle in Indian patients with head and neck cancers, Tumour Biol., 2012,33,543–550 10.1007/s13277-011-0295-xSearch in Google Scholar

[90] Nagadia R., Pandit P., Coman W.B., Cooper-White J., Punyadeera C., miRNAs in head and neck cancer revisited, Cell Oncol. (Dordr), 2013,36,1–7 10.1007/s13402-012-0122-4Search in Google Scholar

[91] Matakidou A., Eisen T., Houlston R.S., TTP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis, Mutagenesis, 2003,18,377–385 10.1093/mutage/geg008Search in Google Scholar

[92] Li G., Sturgis E.M., Wang L.E., Chamberlain R.M., Amos C.I., Spitz M.R., et al., Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck, Carcinogenesis, 2004,25,1911–1916 10.1093/carcin/bgh197Search in Google Scholar

[93] Paterson I.C., Eveson J.W., Prime S.S., Molecular changes in oral cancer may reflect aetiology and ethnic origin, Eur. J. Cancer B. Oral Oncol., 1996,32B,150–153 10.1016/0964-1955(95)00065-8Search in Google Scholar

[94] Hollstein M., Sidransky D., Vogelstein B., Harris C.C., TP53 mutations in human cancers, Science, 1991,253,49–53 10.1126/science.1905840Search in Google Scholar

[95] Levine A.J., Hu W., Feng Z., The TP53 pathway: what questions remain to be explored?, Cell Death Differ., 2006,13,1027–1036 10.1038/sj.cdd.4401910Search in Google Scholar

[96] Matsuoka S., Huang M., Elledge S.J., Linkage of ATM to cell cycle regulation by the Chk2 protein kinase, Science, 1998,282,1893–1897 10.1126/science.282.5395.1893Search in Google Scholar

[97] Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., et al., A role for ATR in the DNA damage-induced phosphorylation of TP53, Genes Dev., 1999,13,152–157 10.1101/gad.13.2.152Search in Google Scholar

[98] Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., et al., Activation of the ATM kinase by ionizing radiation and phosphorylation of TP53, Science, 1998,281,1677–1679 10.1126/science.281.5383.1677Search in Google Scholar

[99] Chen X., Ko L.J., Jayaraman L., Prives C., TP53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells, Genes Dev., 1996,10,2438–2451 10.1101/gad.10.19.2438Search in Google Scholar

[100] Moll U.M., Zaika A., Nuclear and mitochondrial apoptotic pathways of TP53, FEBS Lett., 2001,493,65–69 10.1016/S0014-5793(01)02284-0Search in Google Scholar

[101] Slee E.A., O’Connor D.J., Lu X., To die or not to die: how does TP53 decide?, Oncogene, 2004,23,2809–2818. 10.1038/sj.onc.1207516Search in Google Scholar

[102] Pinar T., Akdur R., Tuncbilek A., Altundag K., Cengiz M., The relationship between occupations and head and neck cancers, J. Natl. Med. Assoc., 2007,99,8–71 Search in Google Scholar

[103] Wake M., The urban/rural divide in head and neck cancer—the effect of atmospheric pollution, Clin. Otolaryngol Allied Sci., 1993,18,298–302 10.1111/j.1365-2273.1993.tb00852.xSearch in Google Scholar

[104] La Vecchia C., Tavani A., Franceschi S., Levi F., Corrao G., Negri E., Epidemiology and prevention of oral cancer, Oral Oncol., 1997,33,302–312 10.1016/S1368-8375(97)00029-8Search in Google Scholar

[105] Zheng T., Boyle P., Willett W.C., Hu H., Dan J., Evstifeeva T.V., et al., A case-control study of oral cancer in Beijing, People’s Republic of China. Associations with nutrient intakes, foods and food groups, Eur. J. Cancer B Oral Oncol., 1993,29B, 45–55 10.1016/0964-1955(93)90010-CSearch in Google Scholar

[106] Lucenteforte E., Garavello W., Bosetti C., La Vecchia C., Dietary factors and oral and pharyngeal cancer risk, Oral Oncol., 2009,45,461–467 10.1016/j.oraloncology.2008.09.002Search in Google Scholar PubMed

[107] Lacko M., Oude Ophuis M.B., Peters W.H., Manni J.J., Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility, Anticancer Res., 2009,29,753–761 Search in Google Scholar

[108] Sharan R.N., Mehrotra R., Choudhury Y., Asotra K., Association of betel nut with carcinogenesis: revisit with a clinical perspective, PLoS One, 2012,7,e42759 10.1371/journal.pone.0042759Search in Google Scholar PubMed PubMed Central

[109] Zhou J., Michaud D.S., Langevin S.M., McClean M.D., Eliot M, Kelsey K.T., Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England, Int. J. Cancer, 2013,132,1911–1917 10.1002/ijc.27839Search in Google Scholar PubMed PubMed Central

[110] Freedman N.D., Schatzkin A., Leitzmann M.F., Hollenbeck A.R., Abnet C.C., Alcohol and head and neck cancer risk in a prospective study, Br. J. Cancer, 2007,96,1469–1474 10.1038/sj.bjc.6603713Search in Google Scholar PubMed PubMed Central

[111] D’Souza G., Dempsey A., The role of HPV in head and neck cancer and review of the HPV vaccine, Prev. Med., 2011,53,S5–S11 10.1016/j.ypmed.2011.08.001Search in Google Scholar PubMed PubMed Central

[112] Feller L., Wood N.H., Khammissa R.A., Lemmer J., Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma, Head Face Med., 2010,6,15 10.1186/1746-160X-6-15Search in Google Scholar PubMed PubMed Central

[113] Bongers V., Braakhuis B.J., Tobi H., Lubsen H., Snow G.B., The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer, Cancer Epidemiol Biomarkers Prev., 1996,5,595–598 Search in Google Scholar

[114] Yu K.K., Zanation A.M., Moss J.R., Yarbrough W.G., Familial head and neck cancer: molecular analysis of a new clinical entity, Laryngoscope, 2002,112,1587–1593 10.1097/00005537-200209000-00010Search in Google Scholar PubMed

[115] Wolter N.E., Wolter J.K., Enepekides D.J., Irwin M.S., Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma, J. Otolaryngol Head Neck Surg., 2012,41,334–344 Search in Google Scholar

[116] Baumeister P., Reiter M., Harreus U., Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention, Oxid. Med. Cell Longev, 2012,2012,902716 10.1155/2012/902716Search in Google Scholar PubMed PubMed Central

[117] Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res. 2004,24,2783–2840 Search in Google Scholar

[118] Piao L., Zhang M., Datta J., Xie X., Su T., Li H., et al., Lipid-based nanoparticle delivery of PremiR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma, Mol. Ther., 2012,20,1261–1269 10.1038/mt.2012.67Search in Google Scholar PubMed PubMed Central

[119] Kumar B., Yadav A., Lang J., Teknos T.N., Kumar P., Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis, PLoS One, 2012,7,e37601 10.1371/journal.pone.0037601Search in Google Scholar PubMed PubMed Central

[120] Kumar M., Lu Z., Takwi A.A., Chen W., Callander N.S., Ramos K.S., et al., Negative regulation of the tumor suppressor TP53 gene by microRNAs, Oncogene, 2011,30,843–853 10.1038/onc.2010.457Search in Google Scholar PubMed PubMed Central

[121] Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., et al., Restoration of TP53 function leads to tumour regression in vivo, Nature, 2007,445,661–665 10.1038/nature05541Search in Google Scholar PubMed

[122] Yan L., Hsu K., Beckman R.A., Antibody-based therapy for solid tumors, Cancer J. 2008,14,178–183 10.1097/PPO.0b013e318172d71aSearch in Google Scholar PubMed

[123] Wu X., Lu C., Chiang S.S., Ajani J.A., Pharmacogenetics in esophageal cancer, Semin. Oncol., 2005,32,S87–S89 10.1053/j.seminoncol.2005.04.031Search in Google Scholar PubMed

[124] Stea B., Gordon J., Clinically relevant biomarkers in targeted radiotherapy, Clin. Exp. Metastasis, 2012,29,853–860 10.1007/s10585-012-9523-zSearch in Google Scholar PubMed

[125] Sayed S.I., Dwivedi R.C., Katna R., Garg A., Pathak K.A., Nutting C.M., et al., Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer, Oral Oncol, 2011,47,237–243 10.1016/j.oraloncology.2011.02.009Search in Google Scholar PubMed

[126] Nagaraj N.S., Evolving’ omics’ technologies for diagnostics of head and neck cancer, Brief Funct. Genomic Proteomic. 2009,8,49–59 10.1093/bfgp/elp004Search in Google Scholar

[127] Gonzalez M.V., Alvarez V., Pello M.F., Menendez M.J., Suarez C., Coto E., Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer, J. Clin. Pathol., 1998,51,294–298 10.1136/jcp.51.4.294Search in Google Scholar

[128] Morita S., Yano M., Tsujinaka T., Akiyama Y., Taniguchi M., Kaneko K., et al., Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma, Int. J. Cancer, 1999, 80, 685–688 10.1002/(SICI)1097-0215(19990301)80:5<685::AID-IJC9>3.0.CO;2-WSearch in Google Scholar

[129] Munirajan A.K., Tutsumi-Ishii Y., Mohanprasad B.K., Hirano Y., Munakata N., Shanmugam G., et al., TP53 gene mutations in oral carcinomas from India, Int. J. Cancer, 1996,66,297–300 10.1002/(SICI)1097-0215(19960503)66:3<297::AID-IJC4>3.0.CO;2-USearch in Google Scholar

[130] Ralhan R., Agarwal S., Nath N., Mathur M., Wasylyk B., Srivastava A., Correlation between TP53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population, Oral Oncol., 2001, 37, 243–250 10.1016/S1368-8375(00)00092-0Search in Google Scholar

[131] van Rensburg E.J., Engelbrecht S, van Heerden W.F., Kotze M.J., Raubenheimer E.J., Detection of TP53 gene mutations in oral squamous cell carcinomas of a black African population sample, Hum. Mutat., 1998,11,39–44 10.1002/(SICI)1098-1004(1998)11:1<39::AID-HUMU6>3.0.CO;2-GSearch in Google Scholar

[132] Thongsuksai P., Boonyaphiphat P., Sriplung H., Sudhikaran W., TP53 mutations in betelassociated oral cancer from Thailand, Cancer Lett., 2003,201,1–7 10.1016/S0304-3835(03)00417-8Search in Google Scholar

[133] Liloglou T., Scholes A.G., Spandidos D.A., Vaughan E.D., Jones A.S., Field J.K., TP53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability, Cancer Res., 1997, 57, 4070–4074 Search in Google Scholar

Published Online: 2014-3-20
Published in Print: 2014-6-1

© 2014 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.2478/s11535-014-0292-3/html
Scroll to top button